Brief: Neurorpm To Deploy Ai-Enabled Digital Biomarker Monitoring For Annovis Bio's Parkinson's Disease Clinical Trial
19/03/2026 11:54
March 19 (Reuters) - Annovis Bio Inc ANVS.N: NEURORPM TO DEPLOY AI-ENABLED DIGITAL BIOMARKER MONITORING FOR ANNOVIS BIO'S PARKINSON'S DISEASE CLINICAL TRIAL Source text: ID:nGNX1sCxRR Further company coverage: ANVS.N ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman